- Cape businessman known for starting NARS dies at 49 (2/23/17)9
- Man shot by police ID'd; witness shares his side of story (2/17/17)31
- MSHP: McLendon shot in side; autopsy refutes witness account (2/19/17)23
- Apparent punch at girls basketball game propels lawmaker into action (2/21/17)4
- Business notebook: Owners ready to roll out the Barrel 131 (2/20/17)6
- Missouri bill would limit transgender school bathroom access (2/22/17)48
- Annual father-daughter dance provides some fun bonding time (2/19/17)1
- SoutheastHEALTH, Washington University School of Medicine announce collaboration (2/24/17)18
- City issues precautionary boil order near Arena Park (2/23/17)
- $22M bond issue would alter Jackson schools (2/22/17)12
Emerson and the drug companies
U.S. Rep. Jo Ann Emerson's Nov. 13 op-ed column bemoaned the drug companies' influence over health care reform. She claims that Congress is in the pockets of the drug companies, that they are the ones steering reform.
I am not sure how Emerson could do this, considering she herself is in their pockets. In 2003, when the Republican Congress was considering expanding Medicare to prescription drugs, Emerson voted for the legislation, giving the drug companies millions of new customers. With these new customers came new profits, and Emerson saw the profits in the form of campaign contributions.
DAVID MITRANI, Rolla, Mo.